SUPPLEMENTARY MATERIALS: A Phase 2 Study of Oral Difelikefalin in Subjects With Chronic Kidney Disease and Moderate-to-Severe Pruritus
Published: 5 April 2023| Version 1 | DOI: 10.17632/fj9cczjj97.1
Contributors:
, , , , Description
Supplementary materials for the publication of Yosipovitch G. A Phase 2 Study of Oral Difelikefalin in Subjects With Chronic Kidney Disease and Moderate-to-Severe Pruritus. J AM Acad Dermatol 2023.
Files
Categories
End Stage Renal Disease, Quality of Life, Chronic Kidney Disease, Opioid Receptor Agonist, Pruritus